Suzuken Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the Six Months of 2017 and for the Full Year Ending March 31, 2018
August 03, 2017
Share
Suzuken Co., Ltd. reported consolidated earnings results for the first quarter ended June 30, 2017. For the period, the company's net sales were ¥527,631 million against ¥532,863 million a year ago. Operating income was ¥2,104 million against ¥273 million a year ago. Net income attributable to owners of the parent was ¥3,099 million against ¥1,074 million a year ago. Net income per share-basic was ¥32.38 against ¥10.84 a year ago. Income before income taxes and non-controlling interests was ¥4,675 million against ¥2,313 million a year ago.
For the six months of 2017, the company expects net sales to be ¥1,031,000 million, operating income to be ¥4,100 million, net income attributable to owners of the parent to be ¥5,500 million and net income per share to be ¥56.92.
For the full year ending March 31, 2018, the company expects net sales to be ¥2,100,000 million, operating income to be ¥10,300 million and net income attributable to owners of the parent to be ¥12,100 million and net income per share to be ¥125.23.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
Suzuken Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the Six Months of 2017 and for the Full Year Ending March 31, 2018